Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with <sup>177</sup>Lu-PSMA
Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PSMA-PET/CT) scans can facilitate diagnosis and treatment of prostate disease. Radiomics signature (RS) is widely used for the analysis of overall survival (OS) in cancer diseases. This study aims at investig...
Main Authors: | Sobhan Moazemi, Annette Erle, Susanne Lütje, Florian C. Gaertner, Markus Essler, Ralph A. Bundschuh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/2/186 |
Similar Items
-
Machine Learning Facilitates Hotspot Classification in PSMA-PET/CT with Nuclear Medicine Specialist Accuracy
by: Sobhan Moazemi, et al.
Published: (2020-08-01) -
Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans
by: Annette Erle, et al.
Published: (2021-07-01) -
Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy
by: Dheeratama Siripongsatian, et al. -
Single-Center Comparison of [<sup>64</sup>Cu]-DOTAGA-PSMA and [<sup>18</sup>F]-PSMA PET–CT for Imaging Prostate Cancer
by: Siroos Mirzaei, et al.
Published: (2021-10-01) -
A Retrospective Comparative Study of Sodium Fluoride Na<sup>18</sup>F-PET/CT and <sup>68</sup>Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis
by: Kalevi Kairemo, et al.
Published: (2022-11-01)